Do both medications require injections
GHK-Cu Anti-Inflammatory & Antioxidant Effects Chronic low-grade inflammation often called inflammaging is now recognized as a central driver of nearly all age-related diseases, including cardiovascular disease, neurodegeneration, metabolic dysfunction, and cancer
Transcript McCall McPhereson: [00:00:00] These medications originally were meant to treat diabetes two decades ago
The KLOW Blend combines BPC-157, TB-500, KPV, and GHK-Cu into a single peptide blend targeting healing, recovery, anti-inflammation, and skin health
Retatrutide is an investigational triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously currently progressing through Phase 3 clinical trials
On average, patients lose between 10-20% of their body weight as early as 6 months with prescription weight loss medications